A MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CB-5945 FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION IN ADULTS TAKING OPIOID THERAPY FOR CHRONIC NON-CANCER PAIN

Registry ID

5945-OIC-12-03

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

CUBIST PHARMACEUTICALS CANADA INC.

Start date

2013-08-07

Last update

2013-06-21

Conditions

• OPIOID-INDUCED CONSTIPATION

Related clinical trials

• A MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CB-5945 FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION IN ADULTS TAKING OPIOID THERAPY FOR CHRONIC NON-CANCER PAIN
• A MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 3 STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLERABILITY OF CB5945 FOR THE TREATMENT OF OPIOIDINDUCED CONSTIPATION IN ADULTS TAKING OPIOID THERAPY FOR CHRONIC NON-CANCER PAIN

View on source registry